Stock Comparison
EXAS vs TDOC
Exact Sciences Corp vs Teladoc Health Inc
The Verdict
EXAS takes this one.
Head-to-Head
Market Cap
P/E Ratio
Profit Margin
Return on Equity
Debt-to-Equity
Overall Risk
DVR Score
The Deep Dive
Exact Sciences continues to demonstrate robust growth in established diagnostics like Cologuard, leveraging its strong market position and commercial infrastructure. The long-term vision for multi-cancer early detection (MCED) taps into a massive, transformative market, offering substantial upside potential. Leadership is strong, and financial health is improving, enabling continued investment in ...
Full EXAS AnalysisTeladoc Health operates in a vast virtual care market with a compelling whole-person health vision, but recent Q1 2026 results show significant headwinds. Revenue declined 2.5% YoY, and free cash flow was a notable -$26.3 million outflow, indicating persistent cash burn and challenging top-line execution. While operating margins improved, overall profitability remains elusive. Competitive advantag...
Full TDOC AnalysisWant More Comparisons?
Run any stock through our deep value analyzer.
Analyze Any Stock →Not Financial Advice
This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.